Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
  1. 2019
  2. Published
  3. 2018
  4. Published

    Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

    Glintborg, B., Kringelbach, T., Bolstad, N., Warren, D. J., Eng, G., Sørensen, I. J., Loft, A. G., Hendricks, O., Hansen, I., Linauskas, A., Nordin, H., Kristensen, S., Lindegaard, H., Jensen, D. V., Goll, G. L., Høgdall, E., Gehin, J., Enevold, C., Nielsen, C. H., Krogh, N. S., Johansen, J. S. & Hetland, M. L., Sep 2018, In : Scandinavian Journal of Rheumatology. 47, 5, p. 418-421 4 p.

    Research output: Contribution to journalLetterResearchpeer-review

  5. Published
  6. 2016
  7. Published

    Non-Medical Switch from Originator To Biosimilar Infliximab among Patients with Inflammatory Rheumatic Disease – Impact on S-Infliximab and Antidrug-Antibodies. Results from The National Danish Rheumatologic Biobank and The Danbio Registry

    Glintborg, B., Kringelbach, T. M., Høgdall, E., Sørensen, I. J., Jensen, D. V., Loft, A. G., Hendricks, O., Jensen Hansen, I. M., Bolstad, N., Grøn, K. L., Eng, G., Enevold, C., Nielsen, C. H., Warren, D., Goll, G., Gehin, J., Johansen, J. S. & Hetland, M. L., 2016, In : Annals of the Rheumatic Diseases. 75, Suppl. 2, p. 224 1 p., THU0123.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  8. Published

    Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry

    Glintborg, B., Kringelbach, T. M., Høgdall, E., Sørensen, I. J., Jensen, D. V., Loft, A. G., Hendricks, O., Hansen, I. M. J., Bolstad, N., Warren, D. J., Gehin, J., Goll, G., Grøn, K. L., Eng, G., Enevold, C., Nielsen, C. H., Johansen, J. S. & Hetland, M. L., 2016, In : Scandinavian Journal of Rheumatology. 45, Suppl. 128, p. 6-7 2 p., OP10.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  9. Published

    Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis – Impact on s-Infliximab and Antidrug-Antibodies. Results from the Danish Rheumatologic Biobank and the Danbio Registry

    Glintborg, B., Kringelbach, T. M., Høgdall, E., Sørensen, I. J., Jensen, D. V., Loft, A. G., Hendricks, O., Hansen, I. M. J., Linauskas, A., Kristensen, S., Lindegaard, H., Nordin, H., Bolstad, N., Warren, D., Warren, D., Gehin, J., Goll, G. L., Grøn, K. L., Eng, G. P., Enevold, C., Nielsen, C. H., Johansen, J. S. & Hetland, M. L., 2016, In : Arthritis & Rheumatology. 68, S10, 1997.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  10. Published

    The Nationwide Danish Rheumatologic Biobank – Paving The Road To Personalized Treatment of Patients with Inflammatory Rheumatic Diseases

    Kringelbach, T. M., Glintborg, B., Johansen, J., Høgdall, E. & Hetland, M. L., 2016, In : Annals of the Rheumatic Diseases. 75, Suppl. 2, p. 1262 1 p., AB1053.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  11. 2015
  12. Published

    Fine-tuned ATP signals are acute mediators in osteocyte mechanotransduction

    Kringelbach, T. M., Aslan, D., Novak, I., Ellegaard, M., Syberg, S., Andersen, C. K. B., Kristiansen, K. A., Vang, O., Schwarz, P. & Jørgensen, N. R., Dec 2015, In : Cellular Signalling. 27, 12, p. 2401-9 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. 2014
  14. Published
  15. Published

    UTP-induced ATP release is a fine-tuned signalling pathway in osteocytes

    Kringelbach, T. M., Aslan, D., Novak, I., Schwarz, P. & Jørgensen, N. R., 2014, In : Purinergic Signalling. 10, 2, p. 337-347

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 59089145